Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content

Beebe’s Structural Heart Program First to Use New Technology to Reduce Stroke Risk

First Watchman FLX


Beebe Healthcare’s Cardiovascular team is the first in Delaware or Maryland to utilize the WATCHMAN FLX Pro implant on Feb. 7.

The WATCHMAN FLX Pro is a left atrial appendage closure device that is used to treat patients who have been diagnosed with non-valvular atrial fibrillation. Also known as AFib, this heart rhythm disorder increases risk for stroke and requires that many patients rely on anticoagulation medications, long-term.

“Beebe is excited to offer the enhanced WATCHMAN FLX Pro left atrial appendage closure device, which features Hemocoat technology to help decrease clot formation, decrease inflammation, and promote faster healing after the implant,” said Mouhanad Freih, MD, Structural Heart Medical Director at Beebe Healthcare. “This device also offers enhanced imaging and additional sizing options to meet the needs of more patients.”

The WATCHMAN FLX Pro is the latest addition to Beebe’s technologically advanced implants to provide the best care for the people in Sussex County.

"The Cardiovascular Services team at Beebe Healthcare is committed to offering state of the art services and cutting-edge technology to our community in an effort to make sure the best cardiac care is available in Sussex County,” said Ehtasham Qureshi, MD, Chief of Cardiology at Beebe. “We were pleased to be the first site in Maryland and Delaware to offer this new technology. Our cardiologists and heart team are here to ensure the best possible care is available for our patients.”

Beebe introduced use of the WATCHMAN device in 2018 and recently celebrated its 200th left atrial appendage closure procedure. Recently, a patient also received the Amulet device implantation in December 2023, which means Beebe’s structural heart team can more effectively treat patients with left atrial openings that vary in depth and size.

“Heart care is an emphasis of the core services we offer at Beebe,” said David A. Tam, MD, MBA, CPHE, FACHE, President & CEO, Beebe Healthcare. “It can be lifesaving or life improving, and the WATCHMAN does both by lessening the risk of stroke and reducing the need of blood thinner medications. We are wholly invested in bringing in these types of innovations and talented clinicians to your local, nonprofit health system. This is how Beebe Healthcare provides the best care for the people who live, work, and visit Sussex County.”

Caption: From left to right, back row, Ehtasham Qureshi, MD, Mouhanad Freih, MD, Georges Dahr, MD; front row, Lori Kline, RN, Jillian Dashiell, MD, Alexi Santry and Bob Henchy from Boston Scientific.